Literature DB >> 18805864

The ageing endothelium, cardiovascular risk and disease in man.

Daniele Versari1, Elena Daghini, Agostino Virdis, Lorenzo Ghiadoni, Stefano Taddei.   

Abstract

Ageing is a major risk factor for cardiovascular disease, not only because there is a process of vascular ageing per se but also because ageing increases the time of exposure to other cardiovascular risk factors. Endothelial dysfunction is now considered an early and important mechanism that predisposes to atherothrombotic damage and thus contributes to the occurrence of cardiovascular events. The normal endothelium exerts a major vascular-protecting role by secreting substances, the most important of which is nitric oxide (NO). In disease conditions (such as the presence of cardiovascular risk factors), activation of endothelial cells can lead to the production and release of contracting factors, which counteract the beneficial effects of NO, and reactive oxygen species (ROS), which cause NO breakdown. Besides the opposite effects on vascular tone, NO and endothelium-derived contracting factors also respectively inhibit and activate several other mechanisms that are involved in the pathogenesis of atherothrombosis. Moreover, endothelial dysfunction is associated with vascular subclinical damage and, importantly, an increasing body of evidence strongly suggests that it might be an independent predictor for the risk of future cardiovascular events. Like the other traditional risk factors, ageing has been demonstrated to be associated with progressive impairment of endothelial function, in both conduit arteries and resistance vessels, mainly because of an increased production of ROS. Therefore, it is conceivable that endothelial dysfunction plays a major role in predisposing to age-related increased cardiovascular risk in the elderly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805864     DOI: 10.1113/expphysiol.2008.043356

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  17 in total

Review 1.  Endothelial dysfunction over the course of coronary artery disease.

Authors:  Enrique Gutiérrez; Andreas J Flammer; Lilach O Lerman; Jaime Elízaga; Amir Lerman; Francisco Fernández-Avilés
Journal:  Eur Heart J       Date:  2013-09-07       Impact factor: 29.983

2.  Effects of ageing and fitness on skin-microvessel vasodilator function in humans.

Authors:  Garry A Tew; Markos Klonizakis; John M Saxton
Journal:  Eur J Appl Physiol       Date:  2010-01-05       Impact factor: 3.078

3.  The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation.

Authors:  Mirjam Schuchardt; Jasmin Prüfer; Nicole Prüfer; Annette Wiedon; Tao Huang; Miriam Chebli; Vera Jankowski; Joachim Jankowski; Monika Schäfer-Korting; Walter Zidek; Markus van der Giet; Markus Tölle
Journal:  J Mol Med (Berl)       Date:  2011-04-13       Impact factor: 4.599

4.  Modulation of postjunctional α-adrenergic vasoconstriction during exercise and exogenous ATP infusions in ageing humans.

Authors:  Brett S Kirby; Anne R Crecelius; Wyatt F Voyles; Frank A Dinenno
Journal:  J Physiol       Date:  2011-02-28       Impact factor: 5.182

5.  Relationships between markers of neurologic and endothelial injury during critical illness and long-term cognitive impairment and disability.

Authors:  Christopher G Hughes; Mayur B Patel; Nathan E Brummel; Jennifer L Thompson; J Brennan McNeil; Pratik P Pandharipande; James C Jackson; Rameela Chandrasekhar; Lorraine B Ware; E Wesley Ely; Timothy D Girard
Journal:  Intensive Care Med       Date:  2018-03-09       Impact factor: 17.440

Review 6.  Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review.

Authors:  Peter Adegbola; Ifewumi Aderibigbe; Wasiu Hammed; Tolulope Omotayo
Journal:  Am J Cardiovasc Dis       Date:  2017-04-15

7.  NOX and inflammation in the vascular adventitia.

Authors:  Gábor Csányi; W Robert Taylor; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

8.  Sulodexide reduces senescence-related changes in human endothelial cells.

Authors:  Katarzyna Suminska-Jasinska; Alicja Polubinska; Marta Ciszewicz; Adam Mikstacki; Artur Antoniewicz; Andrzej Breborowicz
Journal:  Med Sci Monit       Date:  2011-04

9.  The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition.

Authors:  Ihab Hajjar; Meaghan Hart; William Milberg; Vera Novak; Lewis Lipsitz
Journal:  BMC Geriatr       Date:  2009-11-18       Impact factor: 3.921

Review 10.  Exercise and the aging endothelium.

Authors:  Saeid Golbidi; Ismail Laher
Journal:  J Diabetes Res       Date:  2013-08-01       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.